Medical research

Targeting a cell cycle inhibitor promotes beta cell replication

Researchers replicated human pancreatic beta cells—which produce insulin—in a mouse model in which donor cells were transplanted. The newly replicated cells retained features of mature beta cells and showed a physiological ...

Immunology

Engineered anti-toxin antibodies improve efficacy

The effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; however, recent studies suggest that the constant region (Fc) of ...

Diseases, Conditions, Syndromes

Identifying targets of autoantibodies

Patients with the autoimmune disease systemic lupus erythematosus (SLE) produce autoantibodies that target can cause damage to multiple organ systems. The host factors that are targeted by autoantibodies produced by SLE patients ...

Oncology & Cancer

Targeting pancreatic cancer drug resistance

Pancreatic cancer is one of the most deadly and intractable forms of cancer, with a 5-year survival rate of only 6%. Novel therapies are urgently needed, as conventional and targeted approaches have not been successful and ...

page 10 from 13